Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma

Type-2 biomarkers may act as indicators of improvement in FEV<sub>1</sub> and sputum outcomes among patients with severe asthma undergoing dupilumab treatment in real-world settings.

Authors

Institutions

Publication Details

Journal
Allergology International
Published
2024-09-13
DOI
https://doi.org/10.1016/j.alit.2024.08.005
Citations
7
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
2.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma

Nobuaki Miyahara, Naruhiko Sugihara, Etsuko Tagaya, Masayuki Hojo et al.
7 citations
Allergology International
Asthma and respiratory diseases
2.29
article

Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma

Nobuaki Miyahara, Naruhiko Sugihara, Etsuko Tagaya, Masayuki Hojo, Kazuyuki Chibana, Katsunori Masaki, Akihiko Tanaka, Norihiro Harada, Kenji Mizumura, Konomi Kobayashi, Ryosuke Ozoe, Yasuhiro Gon, Hiroyuki Nagase, Kazuhisa Takahashi, Shuichiro Maruoka, Fumio Kumasawa, Junko Terada-Hirashima, Sumiko Abe, Arihiko Kanehiro, Hironori Sagara, Shiho Yamada, Asami Fukuda, Noboru Kitamura, Koichi Fukunaga, Toshihiro Shirai, Taisuke Akamatsu
article en
7 citations

Abstract

Type-2 biomarkers may act as indicators of improvement in FEV<sub>1</sub> and sputum outcomes among patients with severe asthma undergoing dupilumab treatment in real-world settings.

Allergology InternationalVol. 74(1)
Nihon University (JP), SHOWA Medical University (JP), Okayama University (JP), Keio University (JP), Juntendo University (JP), National Center for Global Health and Medicine (JP), Mitsubishi Corporation (Japan) (JP), Himeji Medical Center (JP), Shizuoka General Hospital (JP), Tokyo Women's Medical University (JP), Dokkyo Medical University (JP), Teikyo University (JP)
Zero hunger
Openalex Percentile: Top 11%
Asthma and respiratory diseases
2.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.